|
Journal of Bone and Joint Surgery - British Volume, Vol 90-B, Issue 11,
1417-1421.
doi: 10.1302/0301-620X.90B11.20557 Copyright © 2008 by British Editorial Society of Bone and Joint Surgery The medium-term results of the cemented Exeter femoral component in patients under 40 years of ageD. C. J. de Kam, MD, PhD, Candidate, Research Fellow1; R. L. W. A. Klarenbeek, MD, Resident1; J. W. M. Gardeniers, MD, PhD, Orthopaedic Surgeon1; R. P. H. Veth, MD, PhD, Professor of Orthopaedic Surgery1; and B. W. Schreurs, MD, PhD, Orthopaedic Surgeon11 Department of Orthopaedic Surgery, Radboud University Nijmegen Medical Centre, P. O. Box 9101, 6500 HB Nijmegen, The Netherlands. Correspondence should be sent to Dr B. W. Schreurs; e-mail: b.schreurs{at}orthop.umcn.nl
We evaluated the outcome of 104 consecutive primary cemented Exeter femoral components in 78 patients (34 men, 44 women) under the age of 40 years who underwent total hip replacement between October 1993 and May 2004. The mean age at operation was 31 years (16 to 39). No hip was lost to follow-up, but three patients (four hips) died. None of the deaths were related to the surgery. At a mean follow-up of 6.2 years (2 to 13), three femoral components had been revised for septic loosening. Using Kaplan-Meier survival analysis, the seven-year survival of the component with revision for any reason as the endpoint was 95.8% (95% confidence interval 86.67 to 98.7). The seven-year survival with aseptic femoral loosening as the endpoint was 100% (95% confidence interval 100). The cemented Exeter femoral component in patients under the age of 40 shows promising medium-term results. As it is available in a wide range of sizes and offsets, we could address all types of anatomical variation in this series without the need for custom-made components. This article has been cited by other articles:
|
|
||||||||||||||||||||||||



